Shannon Brownlee is an award-winning essayist, writer, and speaker whose work has appeared in such outlets as the New York Times Sunday Magazine, Time, the Atlantic, and the Washington Post.
Over the last several decades, the Food and Drug Administration has allowed pharma companies to sell hundreds of drugs to patients without adequate evidence that they work and, in many cases, with clear signs that they pose a risk of serious harm.
The Food and Drug Administration has approved controversial drug treatments for Alzheimer’s disease amid excess deaths, questionable efficacy, and conflicts of interest between regulators, patient advocates, and Big Pharma.